SENTCELL LTDActive
Key figures
Like most small UK companies, SENTCELL LTD does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.
Ratios
2024/25Balance sheet structure
Filed accounts2019/20–2024/25
| 2020/21 | 2021/22 | 2022/23 | 2023/24 | 2024/25 | |
|---|---|---|---|---|---|
| Cash at bank and in hand | 6,000,599 | 5,512,816 | — | — | — |
| Total assets | — | 6,101,383 | 5,539,890 | 4,853,066 | 4,498,334 |
| Total liabilities | — | — | — | — | 9,502 |
| Net assets / total equity | 6,105,728 | 6,101,383 | 5,539,891 | 4,853,066 | 4,488,832 |
| Average number of employees | 0 | 0 | 0 | 0 | 0 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Summary: SENTCELL LTD
Company
SENTCELL LTD is a private limited company registered with Companies House under company number 12021050. It was incorporated on 29 May 2019. Its status is active. The registered office is in London (WC1E). Its nature of business (SIC 2007) is research and experimental development on biotechnology (72110).
Accounts
The latest accounts in the database are for 2024/25 (period ending 30 Apr 2025); the company files micro-entity accounts. Net assets were £4,488,832, down 7.5% on the previous year. Total assets were £4,498,334 and total liabilities £9,502. The company had an average of 0 employees. Figures are available for 6 financial years (2019/20–2024/25).
Control and charges
The company has 3 current directors. 3 persons with significant control are registered.
Filing deadlines
The next accounts are due by 31 Jan 2027. The next confirmation statement is due by 31 Oct 2026.